Profile
Toru Yoshimitsu is currently Director at Astellas Institute for Regenerative Medicine and Auditor at PHC Holdings Corp.
Former positions include Director at Astellas Pharma Europe Ltd. from 2017 to 2020 and Director at Astellas Gene Therapies, Inc.
Toru Yoshimitsu active positions
| Companies | Position | Start |
|---|---|---|
| OCATA THERAPEUTICS INC | Director/Board Member | - |
| PHC HOLDINGS CORPORATION | Comptroller/Controller/Auditor | 2025-05-31 |
Former positions of Toru Yoshimitsu
| Companies | Position | End |
|---|---|---|
Astellas Pharma Europe Ltd.
Astellas Pharma Europe Ltd. Pharmaceuticals: MajorHealth Technology Develops and sells pharmaceutical products | Director/Board Member | 2020-03-30 |
| AUDENTES THERAPEUTICS, INC. | Director/Board Member | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Astellas Institute for Regenerative Medicine
Astellas Institute for Regenerative Medicine Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of human pluripotent stem cell technology in the field of regenerative medicine | Health Technology |
Astellas Pharma Europe Ltd.
Astellas Pharma Europe Ltd. Pharmaceuticals: MajorHealth Technology Develops and sells pharmaceutical products | Health Technology |
Astellas Gene Therapies, Inc.
Astellas Gene Therapies, Inc. BiotechnologyHealth Technology Develops and commercializes gene therapy products for patients with serious rare diseases | Health Technology |
PHC Holdings Corp.
PHC Holdings Corp. Medical SpecialtiesHealth Technology Operates a holding company with interests in production and distribution of self-monitoring blood glucose systems | Health Technology |
- Stock Market
- Insiders
- Toru Yoshimitsu
















